On March 5, 2019, the Food and Drug Administration (FDA) approved the first new medication for major depression in decades. The drug is a nasal spray called esketamine, derived from ketamine—an anesthetic that has made waves for its surprising antidepressant effect.
A second therapeutic candidate, LYT-310 (oral cannabidiol), is expected to enter the clinic in Q4 of 2023. A second therapeutic candidate, LYT-310 (oral cannabidiol), is expected to enter the clinic in Q4 of 2023.
CHATHAM, NJ / ACCESSWIRE / April 27, 2023 / A new antidepressant drug candidate being developed by researchers at Tonix Pharmaceuticals Holding Corp. (Nasdaq:TNXP) is said to have mechanistic activity and therapeutic features that set it apart from almost all of the currently approved antidepressants in the U.S.
Takeaway. The FDA has recently approved brexanolone (Zulresso) and esketamine (Spravato) to treat depression. These new approaches for treating depression appear to offer some worthwhile advantages compared to SSRIs and SNRIs, including acting in hours as opposed to days or weeks.
Four new antidepressants have been recently marketed in Australia. They are the selective reversible monoamine oxidase A inhibitor, moclobemide, and the selective serotonin reuptake inhibitors (SSRIs), fluoxetine, paroxetine and sertraline.
The original “happy pill” was fluoxetine, more commonly known as Prozac. This medication, approved for use in 1987, was the first drug of its kind to be prescribed and marketed on a large scale.
As well as esketamine, Auvelity is another recently approved antidepressant, after receiving FDA approval just last year, and is a combination of dextromethorphan – best known as a cough suppressant – and bupropion – used to treat major depressive disorder and facilitate tobacco cessation.
MM-120. The FDA has approved a phase 2b study of an optimized form of LSD for the treatment of anxiety. The drug, called MM-120, is being developed by MindMed and is intended to treat generalized anxiety disorders and other mental conditions. MindMed is expected to begin clinical trials in 2022.
Transcranial magnetic stimulation – TMS stimulates the brain in targeted areas to decrease chronic depression symptoms. With a response rate close to 60%, it resynchronizes and resets the brain. You may be eligible for TMS if you've had two medication trials for depression with minimal or no symptom improvement.
Benzodiazepines (also known as tranquilizers) are the most widely prescribed type of medication for anxiety. Drugs such as Xanax (alprazolam), Klonopin (clonazepam), Valium (diazepam), and Ativan (lorazepam) work quickly, typically bringing relief within 30 minutes to an hour.
Benzodiazepines most commonly used to treat anxiety disorders are clonazepam (Rivotril)*, alprazolam (Xanax) and lorazepam (Ativan). Also used are bromazepam (Lectopam), oxazepam (Serax), chlordiazepoxide (once marketed as Librium), clorazepate (Tranxene) and diazepam (Valium).
SSRI's are anti-depressants and are currently the most popular anti-depression / anti-anxiety drugs as they have fewer side effects than MAOI's. SSRI's include drugs such as Prozac, Luvox and Aropax. SSRI's must be taken on a daily basis for at least a few weeks before they are effective.
Doctors often start by prescribing an SSRI. These drugs are considered safer and generally cause fewer bothersome side effects than other types of antidepressants. SSRIs include citalopram (Celexa), escitalopram (Lexapro), fluoxetine (Prozac), paroxetine (Paxil, Pexeva), sertraline (Zoloft) and vilazodone (Viibryd).
Psychological counseling (psychotherapy) by a psychiatrist, psychologist or other mental health professional can be very effective. For many people, psychotherapy combined with medication works best. It can help identify underlying concerns that may be adding to your depression.
Selective Serotonin Reuptake Inhibitors (SSRIs)
This class includes sertraline, citalopram, escitalopram, paroxetine, fluoxetine and fluvoxamine. SSRIs are: the most commonly prescribed antidepressants in Australia. often a doctor's first choice for most types of depression.
Perhaps the most recognizable among them is Prozac (fluoxetine). It's still the best option for many people, but since it was approved by the Food and Drug Administration (FDA) in 1987, Prozac has been joined by a variety of other antidepressant medications.
Prozac, Paxil, Zoloft, Celexa, and Lexapro, are just a few brands of serotonin that we prescribe for those who suffer from depression, and/or anxiety disorder. There is evidence that these drugs can also improve premenopausal symptoms, even a role in the treatment of obesity and parkinson's disease.
When amphetamines are injected or smoked, they reach the brain quickly and produce a “rush,” or surge of euphoria, immediately. The effects of amphetamines are often different from person to person. Amphetamines can make people: alert, confident and energetic.
Along with Celexa, Lexapro, and Xaxas, these medications — known as SSRIs, or selective serotonin reuptake inhibitors— enhance your mood by producing serotonin in the brain.
SSRIs are usually the first choice medicine for depression because they generally have fewer side effects than most other types of antidepressant.